Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYFrontiers in neurology

Polysomnographic and nocturnal heart rate correlates of cognitive impairment in Parkinson’s disease: a cross-sectional study

  1. 1Department of Neurology, China-Japan Friendship Hospital , ,

Abstract

Objective: To investigate the correlations between cognitive impairment in Parkinson’s disease (PD) and nocturnal video-polysomnography (vPSG) and electrocardiogram (ECG) parameters, evaluating their independent clinical value.

Methods: We analyzed 84 PD patients divided into normal cognition (PD-NC, n = 27), mild cognitive impairment (PD-MCI, n = 27), and dementia (PDD, n = 30) groups. Clinical scales, overnight vPSG, and electrocardiogram parameters were recorded. Multivariable linear regression was used to evaluate independent factors associated with the Montreal Cognitive Assessment (MoCA) scores.

Results: As cognitive impairment progressed, REM sleep latency significantly shortened (128.82 ± 117.32 min in PDD vs. 200.54 ± 90.26 min in PD-NC, p = 0.006). Concurrently, mean nocturnal heart rate (65.80 ± 10.80 bpm) and minimum heart rate (50.77 ± 12.51 bpm) were significantly higher in the PDD group than in the other two groups ( p < 0.01). Multivariable linear regression revealed that, after adjusting for age, education, and UPDRS III score, mean nocturnal heart rate remained independently and negatively associated with MoCA scores ( B = −0.158, β = −0.264, t = −3.018, p = 0.003), while REM sleep latency was independently and positively associated with MoCA scores ( B = 0.010, β = 0.192, t = 2.224, p = 0.029). Collinearity diagnostics showed no significant multicollinearity ( VIF : 1.029–1.261).

Conclusion: Higher mean nocturnal heart rate and shorter REM sleep latency were independently associated with lower global cognitive performance in PD patients. Both measures can be obtained from routine overnight PSG, although their physiological significance remains uncertain. The cross-sectional design and the absence of direct autonomic or cholinergic measurements preclude causal or mechanistic conclusions.

Related

  1. Executive dysfunction in COPD: prevalence and clinical correlates of cognitive impairment : A cross-sectional case–control study
    Hüsniye Aylin Dikbaş, Ruhsel Cörüt, Ali Muhtaroğlu
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Prediction of cognitive impairment in Parkinson’s disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics
    Zikai Zhou, Jie Liu, Lijuan Wang +5
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Enhancing deep sleep with auditory stimulation to boost cognitive training responsiveness in people with Parkinson's disease and mild cognitive impairment: Rationale and design of the double-blind randomized controlled trial PD-CogT-Sleep
    A. Ophey, M. T. Kleinsorge, N. A. Wallimann +8
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  4. The clinical manifestation and neural correlates of cognitive-motor interference in Parkinson’s disease
    Jingjing Wu, Jingwen Chen, Cheng Zhou +13
    NPJ Parkinson's DiseasePeer-reviewedCC BY 4.0Full textNeurologyPMC
  5. Plasma ceramide ratios define metabolic–inflammatory associations with cognitive impairment in Parkinson’s disease
    Nuan Wang, Guoqing Zhang, Chang Li +7
    npj Parkinson's DiseasePeer-reviewedCC BYFull textNeurologyDOAJ
BibTeX
@article{linwei2026polysomnographic,
  title = {{Polysomnographic and nocturnal heart rate correlates of cognitive impairment in Parkinson’s disease: a cross-sectional study}},
  author = {Zhang Linwei and Lv Pu and Wang Lu and Zhang Xiangfei and Wang Kang and Jin Miao},
  journal = {Frontiers in neurology},
  year = {2026},
  month = oct,
  doi = {10.3389/fneur.2026.1913495},
  url = {https://europepmc.org/article/PMC/PMC13690526},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Polysomnographic and nocturnal heart rate correlates of cognitive impairment in Parkinson’s disease: a cross-sectional study
AU  - Zhang Linwei
AU  - Lv Pu
AU  - Wang Lu
AU  - Zhang Xiangfei
AU  - Wang Kang
AU  - Jin Miao
PY  - 2026
DA  - 2026/10/09
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1913495
UR  - https://europepmc.org/article/PMC/PMC13690526
AB  - Objective: To investigate the correlations between cognitive impairment in Parkinson’s disease (PD) and nocturnal video-polysomnography (vPSG) and electrocardiogram (ECG) parameters, evaluating their independent clinical value.  Methods: We analyzed 84 PD patients divided into normal cognition (PD-NC, n = 27), mild cognitive impairment (PD-MCI, n = 27), and dementia (PDD, n = 30) groups. Clinical scales, overnight vPSG, and electrocardiogram parameters were recorded. Multivariable linear regression was used to evaluate independent factors associated with the Montreal Cognitive Assessment (MoCA) scores.  Results: As cognitive impairment progressed, REM sleep latency significantly shortened (128.82 ± 117.32 min in PDD vs. 200.54 ± 90.26 min in PD-NC, p = 0.006). Concurrently, mean nocturnal heart rate (65.80 ± 10.80 bpm) and minimum heart rate (50.77 ± 12.51 bpm) were significantly higher in the PDD group than in the other two groups ( p < 0.01). Multivariable linear regression revealed that, after adjusting for age, education, and UPDRS III score, mean nocturnal heart rate remained independently and negatively associated with MoCA scores ( B = −0.158, β = −0.264, t = −3.018, p = 0.003), while REM sleep latency was independently and positively associated with MoCA scores ( B = 0.010, β = 0.192, t = 2.224, p = 0.029). Collinearity diagnostics showed no significant multicollinearity ( VIF : 1.029–1.261).  Conclusion: Higher mean nocturnal heart rate and shorter REM sleep latency were independently associated with lower global cognitive performance in PD patients. Both measures can be obtained from routine overnight PSG, although their physiological significance remains uncertain. The cross-sectional design and the absence of direct autonomic or cholinergic measurements preclude causal or mechanistic conclusions.
SN  - 1664-2295
ER  -